Hobbs Brian D, Foreman Marilyn G, Bowler Russell, Jacobson Francine, Make Barry J, Castaldi Peter J, San José Estépar Raúl, Silverman Edwin K, Hersh Craig P
1 Channing Division of Network Medicine and.
Ann Am Thorac Soc. 2014 Nov;11(9):1387-94. doi: 10.1513/AnnalsATS.201405-224OC.
The demographic, physiological, and computed tomography (CT) features associated with pneumothorax in smokers with and without chronic obstructive pulmonary disease (COPD) are not clearly defined.
We evaluated the hypothesis that pneumothorax in smokers is associated with male sex, tall and thin stature, airflow obstruction, and increased total and subpleural emphysema.
The study included smokers with and without COPD from the COPDGene Study, with quantitative chest CT analysis. Pleural-based emphysema was assessed on the basis of local histogram measures of emphysema. Pneumothorax history was defined by subject self-report.
Pneumothorax was reported in 286 (3.2%) of 9,062 participants. In all participants, risk of prior pneumothorax was significantly higher in men (odds ratio [OR], 1.55; 95% confidence interval [CI], 1.08-2.22) and non-Hispanic white subjects (OR, 1.90; 95% CI, 1.34-2.69). Risk of prior pneumothorax was associated with increased percent CT emphysema in all participants and participants with COPD (OR, 1.04 for each 1% increase in emphysema; 95% CI, 1.03-1.06). Increased pleural-based emphysema was independently associated with risk of past pneumothorax in all participants (OR, 1.05 for each 1% increase; 95% CI, 1.01-1.10). In smokers with normal spirometry, risk of past pneumothorax was associated with non-Hispanic white race and lifetime smoking intensity (OR, 1.20 for every 10 pack-years; 95% CI, 1.09-1.33).
Among smokers, pneumothorax is associated with male sex, non-Hispanic white race, and increased percentage of total and subpleural CT emphysema. Pneumothorax was not independently associated with height or lung function, even in participants with COPD. Clinical trial registered with www.clinicaltrials.gov (NCT00608764).
患有和未患有慢性阻塞性肺疾病(COPD)的吸烟者气胸相关的人口统计学、生理学和计算机断层扫描(CT)特征尚未明确界定。
我们评估了吸烟者气胸与男性、高瘦体型、气流阻塞以及全肺和胸膜下肺气肿增加相关的假设。
该研究纳入了来自COPDGene研究的患有和未患有COPD的吸烟者,并进行了胸部CT定量分析。基于胸膜的肺气肿根据肺气肿的局部直方图测量进行评估。气胸病史通过受试者自我报告确定。
9062名参与者中有286名(3.2%)报告有气胸。在所有参与者中,既往有气胸的风险在男性(比值比[OR],1.55;95%置信区间[CI],1.08 - 2.22)和非西班牙裔白人受试者中显著更高(OR,1.90;95% CI,1.34 - 2.69)。既往有气胸的风险在所有参与者以及患有COPD的参与者中与CT肺气肿百分比增加相关(肺气肿每增加1%,OR为1.04;95% CI,1.03 - 1.06)。在所有参与者中,基于胸膜的肺气肿增加与既往气胸风险独立相关(每增加1%,OR为1.05;95% CI,1.01 - 1.10)。在肺功能正常的吸烟者中,既往有气胸的风险与非西班牙裔白人种族和终生吸烟强度相关(每10包年,OR为1.20;95% CI,1.09 - 1.33)。
在吸烟者中,气胸与男性、非西班牙裔白人种族以及全肺和胸膜下CT肺气肿百分比增加相关。即使在患有COPD的参与者中,气胸也与身高或肺功能无独立关联。在www.clinicaltrials.gov注册的临床试验(NCT00608764)。